• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Saturday, May 31, 2025
  • Login
National Age
  • Home
  • India
    • National
    • State News
  • World
  • Education
  • Lifestyle
    • Health & Fitness
    • Fashion
    • Travel
    • Food
  • Business
  • Tech
    • App News
    • Gadgets
  • Entertainment
  • Auto
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Education
  • Lifestyle
    • Health & Fitness
    • Fashion
    • Travel
    • Food
  • Business
  • Tech
    • App News
    • Gadgets
  • Entertainment
  • Auto
  • Sports
  • Others
    • Agriculture
    • Science
    • Astrology
    • Finance/Money
    • Press Release
No Result
View All Result
National Age
No Result
View All Result
Home Lifestyle Health & Fitness

Researchers uncover mechanisms related to Multisystem Inflammatory Syndrome in children

National Age by National Age
July 9, 2021
in Health & Fitness
0
Researchers uncover mechanisms related to Multisystem Inflammatory Syndrome in children
Share on FacebookShare on Twitter

New Delhi, Jyoti Singh (India Science Wire): Multisystem inflammatory syndrome in children (MIS-C), affects a few children who have been infected with COVID19. Several body organs, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs, become inflamed, threatening the child’s life. With medical care, many are cured. Yet, the mechanisms by which the conduction results have remained a mystery until now.

The study led by MasschusettsGeneral Hospital for Children (MGHfC) and Brigham and Women’s Hospital,Boston,USA,has revealed the critical mechanism that triggers the onset of Multisystem Inflammatory Syndrome in children.  The research, published in the prestigious Journal of Clinical Investigation says that the SARS-CoV-2 virus travels from the respiratory pathway to the gut andlurks there before entering the bloodstream to reach various parts of the body.

What is MIS-C?

Read ThisAlso

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

May 28, 2025
As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

May 27, 2025

Although it occurs only in one percent of the children and adolescents afflicted with SARS-CoV-2 infections, the rare condition, the Multisystem Inflammatory Syndrome in Children (MIS-C), is a post-covid-19 severe complication, at times fatal.

Puzzlingly, the condition suddenly erupts post-infection when the patients and caregiver are ready to heave a sigh of relief. The debilitating illnesses occursat times, several weeks after testing negative. However, the inflammation is caused by the SARS-CoV-2 virus, which somehow remains hidden and stealthily raises its head once again.

Researchers have found that the virus can hide and remain in the gut long after an initial COVID-19 infection is cleared in the respiratory tract. From the stomach, it spreads into the bloodstream, instigating infection and inflammation in various parts of the body, eventually threatening the child’s life.

The syndrome can occur several weeks after initial infection. Initially, the child experiences symptoms include high fever, abdominal pain, vomiting, diarrhea, rashes and extreme fatigue. Once the infection spreads out from the gut, Child’s immune response goes overdrive to clear the virus from various systems to which it has spread. The hyper-inflammatory response and “cytokine storm” put the life of the young patient under threat.

Eighty percent of children hospitalized with MIS-C develop severe cardiac pathology and face a prolonged hospital stay and extensive recovery period. Current treatment strategies include an aggressive, long-term course of steroids and intravenous immunoglobulin; effective but not adequate.

Mystery solved

Early in the pandemic, other researchers had found that the virus migrates to the gut and can infect it. Thus, often the stool of the infected was found to contain virus particles.  This means if the virus is waiting in the gut long after primary recovery, then the excreta must have virus particles.

To test this hypothesis, the researchers collected the stool samples of the MIS-C affected children. “We realized that 95 percent of the children with MIS-C had SARS-CoV-2 viral particles in their stool, but no or low levels of particles in their noses or throats,” says Yonker, lead author of the paper.

The team hypothesized that SARS-CoV-2 viral particles linger in the gastrointestinal tract of children and then move into the bloodstream. This then leads to the hyper-inflammatory immune response characteristic of MIS-C.  The inner side of the gut is lined with a particular type of cells called gut epithelial cells. The epithelial gut cells have small spaces near the junctions where one cell meets the other. These gaps are the doorway for the transport of products of digestion such as glucose and amino acids from the gut epithelial cells lining the small intestine into the blood.

It was known earlier that big macro-molecule like gluten can seep through the small gaps between the epithelial cells into the bloodstream. The researchers speculated that the virus wiggles the same way into the bloodstream. They later found out that the patients’ blood samples clearly showed the presence of the virus. “This is the first study showing viral particles in the blood of MIS-C coinciding with the hyper-inflammatory response,” says Yonker.

What next?

Co-senior author Alessio Fasano, MD, head of MGHfC’s Division of Pediatric Gastroenterology and Nutrition,  an expert on the mechanics of intestinal immune responses to pathogens, came with an idea to stop the seepage of the virus from the guts into the bloodstream.

In 2000, Fasano and his team at the University of Maryland School of Medicine discovered that zonulin, a protein, regulates intestinal permeability by opening the tight junctions between gut epithelial cells in the small intestine. If one can block the zonulin, the gate will be shut for the virus to ooze into the bloodstream. The MIS-C syndrome can be averted.

Celiac disease is caused by gluten seeping into the blood from the gut. In the early 2000s, Fasano developed larazotide acetate to work as a zonulin blocker to shut the gaps between the gut epithelial cell to prevent gluten from transporting across. This provided a clue.

“Our hypothesis was that larazotide would reduce the hyper-inflammatory by closing the tight junctions and preventing the large spike proteins of the SARS-CoV-2 virus from entering the bloodstream,” says Fasano. The researchers measured high levels of SARS-CoV-2 virus in the stools and high levels of zonulin in the blood of children with MIS-C. This suggested that the SARS-CoV-2 was tunneled through the gaps between the gut cells into the blood.

The immune response in MIS-C is consistent with superantigenic activation of the blocking of the passage of the virus across the cell gap. “The large spike protein–the superantigen–basically holds onto a T-cell and makes it fire off a continuous immune response,” says Yonker

Clinical trials in India

The researchers hoped that zonulin blocker larazotide acetate could help health care providers assist children suffering from the MIS-C syndrome. After obtaining compassionate use permission from the Food and Drug Administration, USA, the research team tried larazotide acetate therapy on children affected with MIS-C. Preliminary data on the efficacy of larazotide acetate is encouraging. This has opened the possible use of larazotide acetate as the first oral treatment for COVID-19 and its complications.

MIS-C cases are increasing in India, and Sir Ganga Ram Hospital, Delhi, has also geared up to tackle it. After a successful trial in the USA, the researchers are now hoping to conduct tests in India. DrDhiren Gupta, Covid Specialist and Pediatric Pulmonologist and Intensivist, Senior Consultant at Sir Ganga Ram Hospital, said that almost 70 percent of these MIS-C patients require ICU bed. “Last year, we also had MIS-C cases, but this time the cases are much higher. At Ganga Ram, we have seen as many as 10 cases in 24 hours. We have transformed one of the acute COVID wards into an MIS-C ward,” he said.

Gearing up

“We need to increase the testing among children,” says Dr Ajay Gambir, Member, Delhi Medical Council. Only a handful of children and young below 18 are tested for COVID19. While pointing out at this stage that tertiary care is not the paramount need, DrGambir says, “We need to improve the primary and secondary care for children under 18 for COVID19; We need customized pulse oximeter for kids as the oximeters used for adults have a different interface.” (India Science Wire)

(*This article is contributed by a freelance journalist.)

Tags: brainchildrenCOVID-19DBTeyesgastrointestinal organsheartICMRkidneyslungsmedical careMIS-CMultisystem Inflammatory SyndromeSARS-CoV-2skinvirus
Share6Tweet4Share1SendShareSend
Previous Post

Riverdale Aerovista becomes the First Housing Society to install a path- breaking Composting system in tricity

Next Post

Kaashu Digital goes global through its new collaboration with the Jamaican and Maldivian governments

National Age

National Age

Related Posts

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay
Health & Fitness

Combining NDT and DMI: A Comprehensive Approach to Developmental Delay

May 28, 2025
As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules
Health & Fitness

As COVID-19 Cases Resurface, Pravek Kalp Promotes Ayurvedic Immunity and Heart Health with Ashwagandha and Arjuna Capsules

May 27, 2025
Global aesthetic thought leader shares innovations at milestone SIME 2025 event in Italy
Health & Fitness

Global aesthetic thought leader shares innovations at milestone SIME 2025 event in Italy

May 23, 2025
Aarogyaa Bharat: The Pune-Based Startup Revolutionizing Access to Medical Equipment Across India
Health & Fitness

Aarogyaa Bharat: The Pune-Based Startup Revolutionizing Access to Medical Equipment Across India

May 21, 2025
Invisalign Treatment Delivers Predictable Results for Adult Patients, Achieving Complete Space Closure in as Little as 8 Months
Health & Fitness

Invisalign Treatment Delivers Predictable Results for Adult Patients, Achieving Complete Space Closure in as Little as 8 Months

May 20, 2025
Dr. Vikas Sharma (LaghaV) – Winner of the 21st Century Emily Dickinson Award
Health & Fitness

Dr. Vikas Sharma (LaghaV) – Winner of the 21st Century Emily Dickinson Award

May 17, 2025
Next Post
Kaashu Digital goes global through its new collaboration with the Jamaican and Maldivian governments

Kaashu Digital goes global through its new collaboration with the Jamaican and Maldivian governments

Dr Jitendra Matlani Dubai based Indian business tycoon sends 50 oxygen concentrators from Dubai to India

Dr Jitendra Matlani, Dubai based Indian business tycoon sends 50 oxygen concentrators from Dubai to India

DG-CSIR visits J&K and takes stock of CSIR’s Lavender Cultivation at Pulwama

Dr. Shekhar Mande, DG-CSIR visits J&K and takes stock of CSIR’s Lavender Cultivation at Pulwama

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Trending
  • Comments
  • Latest
Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

May 26, 2022
Now our E-store India has become an international company

Now our E-store India has become an international company

November 1, 2022
Rotary announces: 20th Global Poster Painting Competition

Rotary announces: 20th Global Poster Painting Competition

June 8, 2022
On 27th & 28th December at Surat Marriott, Athwalines India’s premier fashion showcase Hi Life Exhibition is back

On 27th & 28th December at Surat Marriott, Athwalines India’s premier fashion showcase Hi Life Exhibition is back

December 26, 2023
Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

Pro Cricket Championship Trophy (PCCT) announced the schedule of their selection trials and matches today

27
MPF Investments are mainly aimed at companies in the Indian Market

MPF Investments are mainly aimed at companies in the Indian Market

4

TECNO launches SPARK Power 2 Air: The new Power Play Entertainment device

2

PrivateCourt is all set to revolutionize the concept of Online Dispute Resolution

1
TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

May 30, 2025
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

May 28, 2025

Recent News

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

May 30, 2025
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

Rajarshi Choudhury – Winner of the 21st Century Emily Dickinson Award

May 28, 2025

www.nationalage.com, digital news and story platform bring you the news, articles, stories, and opinions on the latest happenings worldwide covering various sectors like nation, politics, and governance, social sector, review, foreign affairs, defence and security, latest review, lifestyle, entertainment, sports, technology, auto sectors, education, business and start-ups updates, Agriculture, Science, finance, money, food, and culture, etc.

If you have any query regarding Site, Advertisement, and any other issue, please feel free to contact at [email protected]

Follow Us

Browse by Category

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion
  • Finance/Money
  • Food
  • Gadgets
  • Health & Fitness
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • Uncategorized
  • World
TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

TCL Q6 Series: The Real Deal for Tech-Savvy TV Buyers This Year? (Yeah, We’re Looking Closely!)

May 30, 2025
Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

Hemant Suresh Avhad – Winner of the 21st Century Emily Dickinson Award

May 30, 2025
Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

Chander Parkash Malhotra – Winner of the 21st Century Emily Dickinson Award

May 29, 2025
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Copyright © 2021 National Age

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

Copyright © 2021 National Age

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In